Rohto PharmaceuticalLtd (4527) Stock Overview
Manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
4527 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Rohto Pharmaceutical Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥2,488.50 |
| 52 Week High | JP¥2,972.50 |
| 52 Week Low | JP¥1,964.50 |
| Beta | -0.58 |
| 1 Month Change | 5.44% |
| 3 Month Change | -3.06% |
| 1 Year Change | -10.29% |
| 3 Year Change | 10.11% |
| 5 Year Change | 60.29% |
| Change since IPO | 1,066.94% |
Recent News & Updates
Rohto PharmaceuticalLtd (TSE:4527) Is Increasing Its Dividend To ¥22.00
Dec 05
The Rohto Pharmaceutical Co.,Ltd. (TSE:4527) Interim Results Are Out And Analysts Have Published New Forecasts
Nov 15Rohto PharmaceuticalLtd's (TSE:4527) Returns On Capital Not Reflecting Well On The Business
Nov 06Recent updates
Rohto PharmaceuticalLtd (TSE:4527) Is Increasing Its Dividend To ¥22.00
Dec 05The Rohto Pharmaceutical Co.,Ltd. (TSE:4527) Interim Results Are Out And Analysts Have Published New Forecasts
Nov 15Rohto PharmaceuticalLtd's (TSE:4527) Returns On Capital Not Reflecting Well On The Business
Nov 06Is Rohto Pharmaceutical Co.,Ltd. (TSE:4527) Trading At A 33% Discount?
Oct 10These 4 Measures Indicate That Rohto PharmaceuticalLtd (TSE:4527) Is Using Debt Reasonably Well
Sep 11Rohto PharmaceuticalLtd's (TSE:4527) Upcoming Dividend Will Be Larger Than Last Year's
Aug 29Rohto PharmaceuticalLtd (TSE:4527) Is Paying Out A Larger Dividend Than Last Year
Aug 11Analysts Are Updating Their Rohto Pharmaceutical Co.,Ltd. (TSE:4527) Estimates After Its First-Quarter Results
Aug 10Rohto PharmaceuticalLtd (TSE:4527) Is Increasing Its Dividend To ¥21.00
Jul 24Rohto PharmaceuticalLtd's (TSE:4527) Dividend Will Be Increased To ¥21.00
Jul 10Rohto PharmaceuticalLtd (TSE:4527) Could Be Struggling To Allocate Capital
Jun 24The Rohto Pharmaceutical Co.,Ltd. (TSE:4527) Annual Results Are Out And Analysts Have Published New Forecasts
May 15Does Rohto PharmaceuticalLtd (TSE:4527) Have A Healthy Balance Sheet?
Apr 23Rohto PharmaceuticalLtd (TSE:4527) Is Increasing Its Dividend To ¥20.00
Feb 27Rohto Pharmaceutical Co.,Ltd. Just Beat EPS By 6.1%: Here's What Analysts Think Will Happen Next
Feb 15Rohto PharmaceuticalLtd (TSE:4527) Is Increasing Its Dividend To ¥17.00
Feb 13Rohto Pharmaceutical Co.,Ltd.'s (TSE:4527) Intrinsic Value Is Potentially 86% Above Its Share Price
Feb 11Rohto Pharmaceutical Co.,Ltd.'s (TSE:4527) Earnings Haven't Escaped The Attention Of Investors
Jan 09Returns At Rohto PharmaceuticalLtd (TSE:4527) Appear To Be Weighed Down
Dec 24Rohto PharmaceuticalLtd's (TSE:4527) Upcoming Dividend Will Be Larger Than Last Year's
Dec 06Rohto Pharmaceutical Co.,Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Nov 15Rohto Pharmaceutical Co.,Ltd. (TSE:4527) Shares Could Be 25% Below Their Intrinsic Value Estimate
Nov 07These 4 Measures Indicate That Rohto PharmaceuticalLtd (TSE:4527) Is Using Debt Reasonably Well
Oct 20Shareholders Should Be Pleased With Rohto Pharmaceutical Co.,Ltd.'s (TSE:4527) Price
Oct 06Returns At Rohto PharmaceuticalLtd (TSE:4527) Appear To Be Weighed Down
Sep 22Here's Why Rohto PharmaceuticalLtd (TSE:4527) Has Caught The Eye Of Investors
Aug 25Rohto Pharmaceutical Co.,Ltd. Just Missed EPS By 6.8%: Here's What Analysts Think Will Happen Next
Aug 11Does Rohto PharmaceuticalLtd (TSE:4527) Have A Healthy Balance Sheet?
Jul 11Calculating The Fair Value Of Rohto Pharmaceutical Co.,Ltd. (TSE:4527)
Jun 23Unpleasant Surprises Could Be In Store For Rohto Pharmaceutical Co.,Ltd.'s (TSE:4527) Shares
Jun 10Rohto PharmaceuticalLtd (TSE:4527) Has More To Do To Multiply In Value Going Forward
May 14These 4 Measures Indicate That Rohto PharmaceuticalLtd (TSE:4527) Is Using Debt Safely
Apr 03Here's Why We Think Rohto PharmaceuticalLtd (TSE:4527) Is Well Worth Watching
Mar 21Rohto PharmaceuticalLtd (TSE:4527) Is Paying Out A Larger Dividend Than Last Year
Mar 07Estimating The Intrinsic Value Of Rohto Pharmaceutical Co.,Ltd. (TSE:4527)
Feb 26Shareholder Returns
| 4527 | JP Personal Products | JP Market | |
|---|---|---|---|
| 7D | 1.1% | 2.3% | 1.6% |
| 1Y | -10.3% | -7.5% | 22.4% |
Return vs Industry: 4527 underperformed the JP Personal Products industry which returned -7.5% over the past year.
Return vs Market: 4527 underperformed the JP Market which returned 22.4% over the past year.
Price Volatility
| 4527 volatility | |
|---|---|
| 4527 Average Weekly Movement | 2.9% |
| Personal Products Industry Average Movement | 2.8% |
| Market Average Movement | 3.8% |
| 10% most volatile stocks in JP Market | 8.1% |
| 10% least volatile stocks in JP Market | 2.0% |
Stable Share Price: 4527 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 4527's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1899 | 9,144 | Hidetoshi Segi | www.rohto.co.jp |
Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams.
Rohto Pharmaceutical Co.,Ltd. Fundamentals Summary
| 4527 fundamental statistics | |
|---|---|
| Market cap | JP¥568.53b |
| Earnings (TTM) | JP¥35.74b |
| Revenue (TTM) | JP¥333.80b |
Is 4527 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4527 income statement (TTM) | |
|---|---|
| Revenue | JP¥333.80b |
| Cost of Revenue | JP¥146.19b |
| Gross Profit | JP¥187.61b |
| Other Expenses | JP¥151.88b |
| Earnings | JP¥35.74b |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
Feb 12, 2026
| Earnings per share (EPS) | 158.15 |
| Gross Margin | 56.21% |
| Net Profit Margin | 10.71% |
| Debt/Equity Ratio | 16.1% |
How did 4527 perform over the long term?
See historical performance and comparisonDividends
Does 4527 pay a reliable dividends?
See 4527 dividend history and benchmarks| Rohto PharmaceuticalLtd dividend dates | |
|---|---|
| Ex Dividend Date | Mar 30 2026 |
| Dividend Pay Date | Jun 12 2026 |
| Days until Ex dividend | 108 days |
| Days until Dividend pay date | 182 days |
Does 4527 pay a reliable dividends?
See 4527 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/11 15:02 |
| End of Day Share Price | 2025/12/11 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Rohto Pharmaceutical Co.,Ltd. is covered by 10 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Mitsuko Miyasako | Barclays |
| Hiroki Watanabe | Citigroup Inc |
| Katsuro Hirozumi | Daiwa Securities Co. Ltd. |